DVAX
Price
$11.36
Change
+$0.20 (+1.79%)
Updated
Jul 25 closing price
Capitalization
1.62B
5 days until earnings call
RDHL
Price
$1.71
Change
-$0.12 (-6.56%)
Updated
Jul 25 closing price
Capitalization
15.74M
19 days until earnings call
Interact to see
Advertisement

DVAX vs RDHL

Header iconDVAX vs RDHL Comparison
Open Charts DVAX vs RDHLBanner chart's image
Dynavax Technologies
Price$11.36
Change+$0.20 (+1.79%)
Volume$779.7K
Capitalization1.62B
Redhill Biopharma
Price$1.71
Change-$0.12 (-6.56%)
Volume$231.91K
Capitalization15.74M
DVAX vs RDHL Comparison Chart in %
Loading...
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DVAX vs. RDHL commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVAX is a StrongBuy and RDHL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (DVAX: $11.36 vs. RDHL: $1.71)
Brand notoriety: DVAX and RDHL are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DVAX: 45% vs. RDHL: 37%
Market capitalization -- DVAX: $1.62B vs. RDHL: $15.74M
DVAX [@Pharmaceuticals: Other] is valued at $1.62B. RDHL’s [@Pharmaceuticals: Other] market capitalization is $15.74M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DVAX’s FA Score shows that 0 FA rating(s) are green whileRDHL’s FA Score has 0 green FA rating(s).

  • DVAX’s FA Score: 0 green, 5 red.
  • RDHL’s FA Score: 0 green, 5 red.
According to our system of comparison, DVAX is a better buy in the long-term than RDHL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DVAX’s TA Score shows that 5 TA indicator(s) are bullish while RDHL’s TA Score has 4 bullish TA indicator(s).

  • DVAX’s TA Score: 5 bullish, 3 bearish.
  • RDHL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DVAX is a better buy in the short-term than RDHL.

Price Growth

DVAX (@Pharmaceuticals: Other) experienced а +5.97% price change this week, while RDHL (@Pharmaceuticals: Other) price change was -8.06% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.55%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +75.03%.

Reported Earning Dates

DVAX is expected to report earnings on Oct 30, 2025.

RDHL is expected to report earnings on Aug 14, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DVAX($1.62B) has a higher market cap than RDHL($15.7M). DVAX YTD gains are higher at: -11.042 vs. RDHL (-72.464). RDHL has higher annual earnings (EBITDA): 52.8M vs. DVAX (9.67M). DVAX has more cash in the bank: 742M vs. RDHL (7.01M). RDHL has less debt than DVAX: RDHL (2.28M) vs DVAX (257M). DVAX has higher revenues than RDHL: DVAX (232M) vs RDHL (35.7M).
DVAXRDHLDVAX / RDHL
Capitalization1.62B15.7M10,325%
EBITDA9.67M52.8M18%
Gain YTD-11.042-72.46415%
P/E Ratio31.63N/A-
Revenue232M35.7M650%
Total Cash742M7.01M10,579%
Total Debt257M2.28M11,252%
FUNDAMENTALS RATINGS
DVAX vs RDHL: Fundamental Ratings
DVAX
RDHL
OUTLOOK RATING
1..100
2093
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
85
Overvalued
PROFIT vs RISK RATING
1..100
80100
SMR RATING
1..100
93100
PRICE GROWTH RATING
1..100
5493
P/E GROWTH RATING
1..100
9782
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DVAX's Valuation (68) in the Biotechnology industry is in the same range as RDHL (85). This means that DVAX’s stock grew similarly to RDHL’s over the last 12 months.

DVAX's Profit vs Risk Rating (80) in the Biotechnology industry is in the same range as RDHL (100). This means that DVAX’s stock grew similarly to RDHL’s over the last 12 months.

DVAX's SMR Rating (93) in the Biotechnology industry is in the same range as RDHL (100). This means that DVAX’s stock grew similarly to RDHL’s over the last 12 months.

DVAX's Price Growth Rating (54) in the Biotechnology industry is somewhat better than the same rating for RDHL (93). This means that DVAX’s stock grew somewhat faster than RDHL’s over the last 12 months.

RDHL's P/E Growth Rating (82) in the Biotechnology industry is in the same range as DVAX (97). This means that RDHL’s stock grew similarly to DVAX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DVAXRDHL
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 13 days ago
80%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
DVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDHL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMSRX11.52N/A
N/A
Nationwide Small Cap Index R
FCANX12.23N/A
N/A
Fidelity Advisor Asset Manager 30% C
FEIKX81.02N/A
N/A
Fidelity Equity-Income K
PMCKX24.73N/A
N/A
Victory Pioneer Mid Cap Value R6
WIFMX3.90N/A
N/A
Wasatch Frontier Emerg Sm Countrs Instl

DVAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
+1.79%
ACET - DVAX
39%
Loosely correlated
-0.54%
SNDL - DVAX
35%
Loosely correlated
-1.62%
ESPR - DVAX
34%
Loosely correlated
+1.34%
SUPN - DVAX
34%
Loosely correlated
+2.22%
AMRX - DVAX
33%
Poorly correlated
+0.75%
More